Vivani Medical (NASDAQ:VANI) Stock: Insider Gregg Williams Acquires 33,169 Shares

Vivani Medical logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Vivani Medical director Gregg Williams bought 33,169 shares at an average $1.05, spending about $34,827; his reported holdings rose to 37.0 million shares. The article also lists several additional purchases by Williams during the same week.
  • Vivani reported a quarterly loss of $0.08 per share, slightly better than analysts’ $0.09 loss estimate. Shares opened at $1.09, within a 52-week range of $0.80–$1.66.
  • Analyst opinions are mixed: MarketBeat reports a consensus “Hold” rating and a $3.75 target price, while recent research updates included “Sell” ratings.
  • MarketBeat previews top five stocks to own in December.

Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) Director Gregg Williams acquired 33,169 shares of the business's stock in a transaction that occurred on Wednesday, November 18th. The stock was acquired at an average cost of $1.05 per share, with a total value of $34,827.45. Following the completion of the acquisition, the director owned 37,026,034 shares in the company, valued at $38,877,335.70. This trade represents a 0.09% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Gregg Williams also recently made the following trade(s):

  • On Thursday, November 19th, Gregg Williams bought 85,265 shares of Vivani Medical stock. The shares were bought at an average price of $1.09 per share, with a total value of $92,938.85.
  • On Tuesday, November 17th, Gregg Williams bought 29,929 shares of Vivani Medical stock. The shares were acquired at an average cost of $1.05 per share, for a total transaction of $31,425.45.
  • On Monday, November 16th, Gregg Williams bought 2,100 shares of Vivani Medical stock. The stock was purchased at an average price of $1.01 per share, with a total value of $2,121.00.
  • On Friday, November 13th, Gregg Williams acquired 48,100 shares of Vivani Medical stock. The stock was acquired at an average price of $0.99 per share, with a total value of $47,619.00.

Vivani Medical Stock Performance

Shares of VANI stock opened at $1.09 on Friday. Vivani Medical, Inc. has a 52-week low of $0.80 and a 52-week high of $1.66. The stock has a fifty day simple moving average of $1.16 and a two-hundred day simple moving average of $1.23. The firm has a market capitalization of $98.32 million, a PE ratio of -3.41 and a beta of 2.51.

Vivani Medical (NASDAQ:VANI - Get Free Report) last released its quarterly earnings data on Thursday, November 12th. The company reported ($0.08) earnings per share for the quarter, topping analysts' consensus estimates of ($0.09) by $0.01.

Analyst Ratings Changes

Several brokerages recently weighed in on VANI. Wall Street Zen lowered Vivani Medical from a "hold" rating to a "sell" rating in a research report on Sunday, November 15th. Weiss Ratings reissued a "sell (d-)" rating on shares of Vivani Medical in a research report on Friday, October 2nd. Two analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, Vivani Medical presently has a consensus rating of "Hold" and a consensus target price of $3.75.

Read Our Latest Analysis on VANI

Vivani Medical Company Profile

(Get Free Report)

Vivani Medical is a clinical-stage medical technology company developing miniature, implantable devices designed to deliver medicines over extended periods. Its NanoPortal platform is intended to provide sustained drug delivery from a small implant placed under the skin, with the goal of reducing the need for frequent dosing. The company is advancing implant programs based on GLP-1 medicines for chronic conditions, including obesity and type 2 diabetes. These programs remain in development, and their availability and use depend on clinical and regulatory progress.

Featured Stories

Insider Buying and Selling by Quarter for Vivani Medical (NASDAQ:VANI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Vivani Medical Right Now?

Before you consider Vivani Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vivani Medical wasn't on the list.

While Vivani Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines